SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5nd4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD507_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 7	PHE A 169 ALA A 270 ILE A 171 ILE A 209	None None GTP A 500 ( 4.7A) None	0.91A	1oniD-5nd4A: 4.7 1oniF-5nd4A: 4.8	1oniD-5nd4A: 16.21 1oniF-5nd4A: 16.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RMT_D_ADND1504_1 (CLASS B ACID PHOSPHATASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 8	PHE A 267 TYR A 432 LEU A 428 ASP A 424	None	1.04A	1rmtD-5nd4A: undetectable	1rmtD-5nd4A: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDT_A_VIAA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	TYR A 319 ALA A 331 ILE A 335 VAL A 375 ALA A 273	None	1.10A	1udtA-5nd4A: undetectable	1udtA-5nd4A: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDT_A_VIAA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	TYR A 319 ALA A 331 ILE A 335 VAL A 375 PHE A 296	None	1.11A	1udtA-5nd4A: undetectable	1udtA-5nd4A: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X70_B_715B801_2 (DIPEPTIDYL PEPTIDASE IV)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	3 / 3	PHE A 395 TYR A 408 TYR A 103	None	0.87A	1x70B-5nd4A: undetectable	1x70B-5nd4A: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XP0_A_VDNA201_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 10	TYR A 319 ALA A 331 ILE A 335 VAL A 375 ALA A 273	None	1.16A	1xp0A-5nd4A: undetectable	1xp0A-5nd4A: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XP0_A_VDNA201_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 10	TYR A 319 ALA A 331 ILE A 335 VAL A 375 PHE A 296	None	1.10A	1xp0A-5nd4A: undetectable	1xp0A-5nd4A: 20.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Z2B_C_VLBC800_2 (TUBULIN ALPHA CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 5	PRO A 325 VAL A 328 VAL A 353 ILE A 355	None	0.69A	1z2bC-5nd4A: 55.9	1z2bC-5nd4A: 92.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASE II)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	HIS A 107 HIS A 139 VAL A 137 THR A 194 THR A 193	None	1.04A	1zgfA-5nd4A: undetectable	1zgfA-5nd4A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BM9_A_SAMA301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	LEU A 428 LEU A 195 GLU A 168 SER A 198 ASP A 205	None	1.05A	2bm9A-5nd4A: 3.7	2bm9A-5nd4A: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2GL0_B_ADNB902_1 (CONSERVED HYPOTHETICAL PROTEIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 11	PHE A 169 HIS A 8 ASN A 228 ILE A 171 ALA A 19	None None GTP A 500 (-3.0A) GTP A 500 ( 4.7A) None	1.43A	2gl0B-5nd4A: undetectable 2gl0C-5nd4A: undetectable	2gl0B-5nd4A: 17.35 2gl0C-5nd4A: 17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IZQ_A_DVAA8_0 (GRAMICIDIN D)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	3 / 3	VAL A 437 TRP A 346 VAL A 435	None	0.90A	2izqA-5nd4A: undetectable 2izqB-5nd4A: undetectable	2izqA-5nd4A: 3.21 2izqB-5nd4A: 3.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XKW_B_P1BB1475_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	ILE A 209 SER A 237 ALA A 240 LEU A 23 ILE A 231	None	1.21A	2xkwB-5nd4A: undetectable	2xkwB-5nd4A: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BL1_A_BL1A300_1 (CARBONIC ANHYDRASE 2)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	HIS A 107 HIS A 139 VAL A 137 THR A 194 THR A 193	None	0.88A	3bl1A-5nd4A: undetectable	3bl1A-5nd4A: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IXL_A_PACA5000_0 (ARYLMALONATE DECARBOXYLASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 10	THR A 150 SER A 151 SER A 147 GLY A 146 GLY A 143	None None None GTP A 500 ( 4.4A) GTP A 500 (-3.0A)	1.41A	3ixlA-5nd4A: 2.0	3ixlA-5nd4A: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IXL_A_PACA5000_0 (ARYLMALONATE DECARBOXYLASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 10	THR A 150 SER A 151 SER A 147 GLY A 146 GLY A 144	None None None GTP A 500 ( 4.4A) GTP A 500 (-2.9A)	1.08A	3ixlA-5nd4A: 2.0	3ixlA-5nd4A: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	6 / 12	ALA A 331 THR A 334 ALA A 333 ALA A 330 VAL A 288 ALA A 294	None	1.46A	3mg0Y-5nd4A: undetectable 3mg0Z-5nd4A: undetectable	3mg0Y-5nd4A: 19.09 3mg0Z-5nd4A: 21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TM4_A_SAMA401_1 (TRNA (GUANINE N2-)-METHYLTRANSFERA SE TRM14)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 5	HIS A 107 SER A 151 THR A 190 GLU A 155	None	1.25A	3tm4A-5nd4A: 3.9	3tm4A-5nd4A: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TM4_B_SAMB401_1 (TRNA (GUANINE N2-)-METHYLTRANSFERA SE TRM14)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 5	HIS A 107 SER A 151 THR A 190 GLU A 155	None	1.21A	3tm4B-5nd4A: 3.8	3tm4B-5nd4A: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACB_C_DXCC1479_0 (TRANSLATION ELONGATION FACTOR SELB)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 5	THR A 109 ILE A 110 GLU A 97 PHE A 149	None	1.49A	4acbC-5nd4A: 3.8	4acbC-5nd4A: 22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_B_CQAB302_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 8	GLU A 433 GLU A 429 TYR A 432 GLY A 310	None	0.91A	4fgzA-5nd4A: 3.0 4fgzB-5nd4A: 2.9	4fgzA-5nd4A: 19.26 4fgzB-5nd4A: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FR0_A_SAMA401_0 (ARSENIC METHYLTRANSFERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	GLY A 106 GLY A 148 ILE A 110 GLU A 97 ASN A 101	None None None None GTP A 500 (-3.3A)	1.12A	4fr0A-5nd4A: 3.2	4fr0A-5nd4A: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HTF_A_SAMA301_0 (S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	6 / 12	GLY A 146 GLY A 144 GLY A 143 SER A 187 VAL A 9 VAL A 137	GTP A 500 ( 4.4A) GTP A 500 (-2.9A) GTP A 500 (-3.0A) None None None	1.25A	4htfA-5nd4A: 3.3	4htfA-5nd4A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HTF_B_SAMB301_0 (S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	6 / 12	GLY A 146 GLY A 144 GLY A 143 SER A 187 VAL A 9 VAL A 137	GTP A 500 ( 4.4A) GTP A 500 (-2.9A) GTP A 500 (-3.0A) None None None	1.29A	4htfB-5nd4A: undetectable	4htfB-5nd4A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0Z_A_MZMA308_1 (CARBONIC ANHYDRASE 2)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	HIS A 139 LEU A 119 VAL A 137 THR A 194 THR A 193	None	1.02A	4k0zA-5nd4A: undetectable	4k0zA-5nd4A: 21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MK4_A_CHDA503_0 (FERROCHELATASE, MITOCHONDRIAL)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 10	LEU A 153 LEU A 152 ARG A 123 LYS A 124 THR A 145	None None None None GTP A 500 (-4.0A)	1.24A	4mk4A-5nd4A: 2.7	4mk4A-5nd4A: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YMG_A_SAMA1001_0 (PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	GLY A 142 TYR A 185 SER A 170 ALA A 12 ASN A 206	None None None GTP A 500 (-3.3A) GTP A 500 (-3.5A)	1.41A	4ymgA-5nd4A: 4.2	4ymgA-5nd4A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_H_SAMH301_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 12	ALA A 126 GLY A 134 GLY A 131 LEU A 167 GLU A 168	None	1.01A	5c0oH-5nd4A: 3.9	5c0oH-5nd4A: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECM_A_LEUA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 5	THR A 382 ALA A 383 TYR A 312 HIS A 309	None	1.05A	5ecmA-5nd4A: undetectable	5ecmA-5nd4A: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GWZ_D_010D6_0 (N-[(5-METHYLISOXAZOL -3-YL)CARBONYL]ALANY L-L-VALYL-N~1~-((1R, 2Z)-4-(BENZYLOXY)-4- OXO-1-{[(3R)-2-OXOPY RROLIDIN-3-YL]METHYL }BUT-2-ENYL)-L-LEUCI NAMIDE PEDV MAIN PROTEASE)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	3 / 3	MET A 313 HIS A 266 GLY A 436	None	0.84A	5gwzB-5nd4A: undetectable	5gwzB-5nd4A: 20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGY_A_ERYA403_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	4 / 6	TYR A 161 ASP A 120 ILE A 115 ARG A 156	None	1.36A	5igyA-5nd4A: undetectable	5igyA-5nd4A: 22.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J2T_C_VLBC503_2 (TUBULIN ALPHA-1B CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	8 / 12	PRO A 325 VAL A 328 ASN A 329 ILE A 332 ALA A 333 PHE A 351 GLY A 354 ILE A 355	None	1.01A	5j2tC-5nd4A: 54.1	5j2tC-5nd4A: 92.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J2T_C_VLBC503_2 (TUBULIN ALPHA-1B CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	8 / 12	PRO A 325 VAL A 328 ILE A 332 ALA A 333 PHE A 351 VAL A 353 GLY A 354 ILE A 355	None	1.01A	5j2tC-5nd4A: 54.1	5j2tC-5nd4A: 92.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JH7_B_6K9B503_0 (TUBULIN BETA-2B CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 11	GLN A 11 GLU A 183 PRO A 222 TYR A 224 LEU A 227	GTP A 500 ( 3.1A) GTP A 500 (-3.3A) None GTP A 500 (-3.2A) GTP A 500 ( 4.1A)	0.77A	5jh7B-5nd4A: 51.3	5jh7B-5nd4A: 38.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JH7_D_6K9D502_0 (TUBULIN BETA-2B CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 11	GLN A 11 ASN A 101 PRO A 222 TYR A 224 LEU A 227	GTP A 500 ( 3.1A) GTP A 500 (-3.3A) None GTP A 500 (-3.2A) GTP A 500 ( 4.1A)	0.97A	5jh7D-5nd4A: 51.7	5jh7D-5nd4A: 38.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JH7_D_6K9D502_0 (TUBULIN BETA-2B CHAIN)	5nd4	TUBULIN ALPHA CHAIN (Bos taurus)	5 / 11	GLN A 11 GLU A 183 PRO A 222 TYR A 224 LEU A 227	GTP A 500 ( 3.1A) GTP A 500 (-3.3A) None GTP A 500 (-3.2A) GTP A 500 ( 4.1A)	0.74A	5jh7D-5nd4A: 51.7	5jh7D-5nd4A: 38.90

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ONI_D_BEZD507_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"PHE A 169;ALA A 270;ILE A 171;ILE A 209","None;None;GTP A 500 ( 4.7A);None","0.91A","1oniD-5nd4A:4.7;1oniF-5nd4A:4.8","1oniD-5nd4A:16.21;1oniF-5nd4A:16.21"],["1RMT_D_ADND1504_1","CLASS B ACID PHOSPHATASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"PHE A 267;TYR A 432;LEU A 428;ASP A 424","None","1.04A","1rmtD-5nd4A:undetectable","1rmtD-5nd4A:20.62"],["1UDT_A_VIAA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"TYR A 319;ALA A 331;ILE A 335;VAL A 375;ALA A 273","None","1.10A","1udtA-5nd4A:undetectable","1udtA-5nd4A:22.45"],["1UDT_A_VIAA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"TYR A 319;ALA A 331;ILE A 335;VAL A 375;PHE A 296","None","1.11A","1udtA-5nd4A:undetectable","1udtA-5nd4A:22.45"],["1X70_B_715B801_2","DIPEPTIDYL PEPTIDASE IV","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",3,"PHE A 395;TYR A 408;TYR A 103","None","0.87A","1x70B-5nd4A:undetectable","1x70B-5nd4A:21.67"],["1XP0_A_VDNA201_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"TYR A 319;ALA A 331;ILE A 335;VAL A 375;ALA A 273","None","1.16A","1xp0A-5nd4A:undetectable","1xp0A-5nd4A:20.99"],["1XP0_A_VDNA201_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"TYR A 319;ALA A 331;ILE A 335;VAL A 375;PHE A 296","None","1.10A","1xp0A-5nd4A:undetectable","1xp0A-5nd4A:20.99"],["1Z2B_C_VLBC800_2","TUBULIN ALPHA CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"PRO A 325;VAL A 328;VAL A 353;ILE A 355","None","0.69A","1z2bC-5nd4A:55.9","1z2bC-5nd4A:92.92"],["1ZGF_A_TRUA300_1","CARBONIC ANHYDRASE II","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"HIS A 107;HIS A 139;VAL A 137;THR A 194;THR A 193","None","1.04A","1zgfA-5nd4A:undetectable","1zgfA-5nd4A:21.93"],["2BM9_A_SAMA301_0","CEPHALOSPORIN HYDROXYLASE CMCI","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"LEU A 428;LEU A 195;GLU A 168;SER A 198;ASP A 205","None","1.05A","2bm9A-5nd4A:3.7","2bm9A-5nd4A:21.46"],["2GL0_B_ADNB902_1","CONSERVED HYPOTHETICAL PROTEIN;CONSERVED HYPOTHETICAL PROTEIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"PHE A 169;HIS A   8;ASN A 228;ILE A 171;ALA A  19","None;None;GTP A 500 (-3.0A);GTP A 500 ( 4.7A);None","1.43A","2gl0B-5nd4A:undetectable;2gl0C-5nd4A:undetectable","2gl0B-5nd4A:17.35;2gl0C-5nd4A:17.35"],["2IZQ_A_DVAA8_0","GRAMICIDIN D","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",3,"VAL A 437;TRP A 346;VAL A 435","None","0.90A","2izqA-5nd4A:undetectable;2izqB-5nd4A:undetectable","2izqA-5nd4A:3.21;2izqB-5nd4A:3.21"],["2XKW_B_P1BB1475_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"ILE A 209;SER A 237;ALA A 240;LEU A  23;ILE A 231","None","1.21A","2xkwB-5nd4A:undetectable","2xkwB-5nd4A:20.62"],["3BL1_A_BL1A300_1","CARBONIC ANHYDRASE 2","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"HIS A 107;HIS A 139;VAL A 137;THR A 194;THR A 193","None","0.88A","3bl1A-5nd4A:undetectable","3bl1A-5nd4A:21.72"],["3IXL_A_PACA5000_0","ARYLMALONATE DECARBOXYLASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"THR A 150;SER A 151;SER A 147;GLY A 146;GLY A 143","None;None;None;GTP A 500 ( 4.4A);GTP A 500 (-3.0A)","1.41A","3ixlA-5nd4A:2.0","3ixlA-5nd4A:21.20"],["3IXL_A_PACA5000_0","ARYLMALONATE DECARBOXYLASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"THR A 150;SER A 151;SER A 147;GLY A 146;GLY A 144","None;None;None;GTP A 500 ( 4.4A);GTP A 500 (-2.9A)","1.08A","3ixlA-5nd4A:2.0","3ixlA-5nd4A:21.20"],["3MG0_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",6,"ALA A 331;THR A 334;ALA A 333;ALA A 330;VAL A 288;ALA A 294","None","1.46A","3mg0Y-5nd4A:undetectable;3mg0Z-5nd4A:undetectable","3mg0Y-5nd4A:19.09;3mg0Z-5nd4A:21.39"],["3TM4_A_SAMA401_1","TRNA (GUANINE N2-)-METHYLTRANSFERASE TRM14","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"HIS A 107;SER A 151;THR A 190;GLU A 155","None","1.25A","3tm4A-5nd4A:3.9","3tm4A-5nd4A:22.76"],["3TM4_B_SAMB401_1","TRNA (GUANINE N2-)-METHYLTRANSFERASE TRM14","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"HIS A 107;SER A 151;THR A 190;GLU A 155","None","1.21A","3tm4B-5nd4A:3.8","3tm4B-5nd4A:22.76"],["4ACB_C_DXCC1479_0","TRANSLATION ELONGATION FACTOR SELB","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"THR A 109;ILE A 110;GLU A  97;PHE A 149","None","1.49A","4acbC-5nd4A:3.8","4acbC-5nd4A:22.62"],["4FGZ_B_CQAB302_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"GLU A 433;GLU A 429;TYR A 432;GLY A 310","None","0.91A","4fgzA-5nd4A:3.0;4fgzB-5nd4A:2.9","4fgzA-5nd4A:19.26;4fgzB-5nd4A:19.26"],["4FR0_A_SAMA401_0","ARSENIC METHYLTRANSFERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"GLY A 106;GLY A 148;ILE A 110;GLU A  97;ASN A 101","None;None;None;None;GTP A 500 (-3.3A)","1.12A","4fr0A-5nd4A:3.2","4fr0A-5nd4A:22.78"],["4HTF_A_SAMA301_0","S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",6,"GLY A 146;GLY A 144;GLY A 143;SER A 187;VAL A   9;VAL A 137","GTP A 500 ( 4.4A);GTP A 500 (-2.9A);GTP A 500 (-3.0A);None;None;None","1.25A","4htfA-5nd4A:3.3","4htfA-5nd4A:21.96"],["4HTF_B_SAMB301_0","S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",6,"GLY A 146;GLY A 144;GLY A 143;SER A 187;VAL A   9;VAL A 137","GTP A 500 ( 4.4A);GTP A 500 (-2.9A);GTP A 500 (-3.0A);None;None;None","1.29A","4htfB-5nd4A:undetectable","4htfB-5nd4A:21.96"],["4K0Z_A_MZMA308_1","CARBONIC ANHYDRASE 2","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"HIS A 139;LEU A 119;VAL A 137;THR A 194;THR A 193","None","1.02A","4k0zA-5nd4A:undetectable","4k0zA-5nd4A:21.82"],["4MK4_A_CHDA503_0","FERROCHELATASE, MITOCHONDRIAL","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"LEU A 153;LEU A 152;ARG A 123;LYS A 124;THR A 145","None;None;None;None;GTP A 500 (-4.0A)","1.24A","4mk4A-5nd4A:2.7","4mk4A-5nd4A:21.40"],["4YMG_A_SAMA1001_0","PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"GLY A 142;TYR A 185;SER A 170;ALA A  12;ASN A 206","None;None;None;GTP A 500 (-3.3A);GTP A 500 (-3.5A)","1.41A","4ymgA-5nd4A:4.2","4ymgA-5nd4A:20.00"],["5C0O_H_SAMH301_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"ALA A 126;GLY A 134;GLY A 131;LEU A 167;GLU A 168","None","1.01A","5c0oH-5nd4A:3.9","5c0oH-5nd4A:22.30"],["5ECM_A_LEUA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"THR A 382;ALA A 383;TYR A 312;HIS A 309","None","1.05A","5ecmA-5nd4A:undetectable","5ecmA-5nd4A:22.89"],["5GWZ_D_010D6_0","N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE;PEDV MAIN PROTEASE","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",3,"MET A 313;HIS A 266;GLY A 436","None","0.84A","5gwzB-5nd4A:undetectable","5gwzB-5nd4A:20.67"],["5IGY_A_ERYA403_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",4,"TYR A 161;ASP A 120;ILE A 115;ARG A 156","None","1.36A","5igyA-5nd4A:undetectable","5igyA-5nd4A:22.17"],["5J2T_C_VLBC503_2","TUBULIN ALPHA-1B CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",8,"PRO A 325;VAL A 328;ASN A 329;ILE A 332;ALA A 333;PHE A 351;GLY A 354;ILE A 355","None","1.01A","5j2tC-5nd4A:54.1","5j2tC-5nd4A:92.92"],["5J2T_C_VLBC503_2","TUBULIN ALPHA-1B CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",8,"PRO A 325;VAL A 328;ILE A 332;ALA A 333;PHE A 351;VAL A 353;GLY A 354;ILE A 355","None","1.01A","5j2tC-5nd4A:54.1","5j2tC-5nd4A:92.92"],["5JH7_B_6K9B503_0","TUBULIN BETA-2B CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"GLN A  11;GLU A 183;PRO A 222;TYR A 224;LEU A 227","GTP A 500 ( 3.1A);GTP A 500 (-3.3A);None;GTP A 500 (-3.2A);GTP A 500 ( 4.1A)","0.77A","5jh7B-5nd4A:51.3","5jh7B-5nd4A:38.90"],["5JH7_D_6K9D502_0","TUBULIN BETA-2B CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"GLN A  11;ASN A 101;PRO A 222;TYR A 224;LEU A 227","GTP A 500 ( 3.1A);GTP A 500 (-3.3A);None;GTP A 500 (-3.2A);GTP A 500 ( 4.1A)","0.97A","5jh7D-5nd4A:51.7","5jh7D-5nd4A:38.90"],["5JH7_D_6K9D502_0","TUBULIN BETA-2B CHAIN","5nd4","TUBULIN ALPHA CHAIN","Bos taurus",5,"GLN A  11;GLU A 183;PRO A 222;TYR A 224;LEU A 227","GTP A 500 ( 3.1A);GTP A 500 (-3.3A);None;GTP A 500 (-3.2A);GTP A 500 ( 4.1A)","0.74A","5jh7D-5nd4A:51.7","5jh7D-5nd4A:38.90"]]